The melanomas: a synthesis of epidemiological, clinical, histopathological, genetic, and biological aspects, supporting distinct subtypes, causal pathways, and cells of origin
暂无分享,去创建一个
[1] D. Whiteman,et al. Melanocytic nevi in very young children: the role of phenotype, sun exposure, and sun protection. , 2011, Journal of the American Academy of Dermatology.
[2] J. Choi,et al. Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta‐analysis , 2011, The British journal of dermatology.
[3] A. Hara,et al. Functionally distinct melanocyte populations revealed by reconstitution of hair follicles in mice , 2011, Pigment cell & melanoma research.
[4] N. Carter,et al. Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.
[5] A. Bowcock,et al. Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas , 2010, Science.
[6] D. Schadendorf,et al. Genetic and morphologic features for melanoma classification , 2010, Pigment cell & melanoma research.
[7] A. Hauschild,et al. Association between the germline MC1R variants and somatic BRAF/NRAS mutations in melanoma tumors. , 2010, The Journal of investigative dermatology.
[8] J. O'Brien,et al. Mutations in GNA11 in uveal melanoma. , 2010, The New England journal of medicine.
[9] D. Whiteman,et al. Estimating the attributable fraction for melanoma: A meta‐analysis of pigmentary characteristics and freckling , 2010, International journal of cancer.
[10] V. Hearing,et al. The fibroblast-derived paracrine factor neuregulin-1 has a novel role in regulating the constitutive color and melanocyte function in human skin , 2010, Journal of Cell Science.
[11] J. Barrett,et al. Melanocytic Nevi, Nevus Genes, and Melanoma Risk in a Large Case-Control Study in the United Kingdom , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[12] I. Adameyko,et al. Glial versus melanocyte cell fate choice: Schwann cell precursors as a cellular origin of melanocytes , 2010, Cellular and Molecular Life Sciences.
[13] M. Ziman,et al. PAX3 Expression in Normal Skin Melanocytes and Melanocytic Lesions (Naevi and Melanomas) , 2010, PloS one.
[14] M. Herlyn,et al. Human dermal stem cells differentiate into functional epidermal melanocytes , 2010, Journal of Cell Science.
[15] N. Dhomen,et al. Inducible expression of V600EBraf using tyrosinase‐driven Cre recombinase results in embryonic lethality , 2010, Pigment cell & melanoma research.
[16] D. Whiteman,et al. Familial Melanoma: A Meta-analysis and Estimates of Attributable Fraction , 2010, Cancer Epidemiology, Biomarkers & Prevention.
[17] W. Pavan,et al. NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation , 2009, Pigment cell & melanoma research.
[18] G. Reifenberger,et al. Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system , 2009, Acta Neuropathologica.
[19] U. Suter,et al. Schwann Cell Precursors from Nerve Innervation Are a Cellular Origin of Melanocytes in Skin , 2009, Cell.
[20] Y. Korchev,et al. Functional neurons and melanocytes induced from immortal lines of postnatal neural crest-like stem cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] C. Garbe,et al. Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma , 2009, British Journal of Cancer.
[22] A. Hara,et al. Two distinct types of mouse melanocyte: differential signaling requirement for the maintenance of non-cutaneous and dermal versus epidermal melanocytes , 2009, Development.
[23] J. Malvehy,et al. Genome-wide association study identifies three loci associated with melanoma risk , 2009, Nature Genetics.
[24] T. Spector,et al. Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi , 2009, Nature Genetics.
[25] S. Cramer. Stem Cells for Epidermal Melanocytes-A Challenge for Students of Dermatopathology , 2009, The American Journal of dermatopathology.
[26] R. DePinho,et al. BRafV600E cooperates with Pten silencing to elicit metastatic melanoma , 2009, Nature Genetics.
[27] T. Mack,et al. Nevus density and melanoma risk in women: A pooled analysis to test the divergent pathway hypothesis , 2009, International journal of cancer.
[28] T. Gojobori,et al. Specific expression of Gsta4 in mouse cochlear melanocytes: a novel role for hearing and melanocyte differentiation , 2009, Pigment cell & melanoma research.
[29] N. Yoo,et al. Somatic mutation of GNAQ gene is rare in common solid cancers and leukemias , 2009, Acta oncologica.
[30] E. Simpson,et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi , 2008, Nature.
[31] M Laurin Council,et al. Oncogenic mutations in GNAQ occur early in uveal melanoma. , 2008, Investigative ophthalmology & visual science.
[32] Susan Muller,et al. KIT Gene Mutations and Copy Number in Melanoma Subtypes , 2008, Clinical Cancer Research.
[33] D. Elder,et al. MC1R variants increase risk of melanomas harboring BRAF mutations. , 2008, The Journal of investigative dermatology.
[34] D. Pinkel,et al. Distribution and significance of occult intraepidermal tumor cells surrounding primary melanoma. , 2008, The Journal of investigative dermatology.
[35] Christopher Y. Park,et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects , 2008, Nature Genetics.
[36] Kari Stefansson,et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma , 2008, Nature Genetics.
[37] Jane Fridlyand,et al. Improving Melanoma Classification by Integrating Genetic and Morphologic Features , 2008, PLoS medicine.
[38] C. Tohyama,et al. Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/ β‐catenin signaling in keratinocytes , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[39] Snæbjörn Pálsson,et al. Genetic determinants of hair, eye and skin pigmentation in Europeans , 2007, Nature Genetics.
[40] R. Millikan,et al. Number of Nevi and Early-Life Ambient UV Exposure Are Associated with BRAF-Mutant Melanoma , 2007, Cancer Epidemiology Biomarkers & Prevention.
[41] V. Hearing,et al. The effects of dickkopf 1 on gene expression and Wnt signaling by melanocytes: mechanisms underlying its suppression of melanocyte function and proliferation. , 2007, The Journal of investigative dermatology.
[42] V. Siskind,et al. A comparison of the anatomic distribution of cutaneous melanoma in two populations with different levels of sunlight: the west of Scotland and Queensland, Australia 1982–2001 , 2007, Cancer Causes & Control.
[43] M. Trivett,et al. Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma. , 2007, The Journal of investigative dermatology.
[44] L. Larue,et al. Notch1 and Notch2 receptors influence progressive hair graying in a dose‐dependent manner , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.
[45] J. Lundeberg,et al. NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing , 2006, Melanoma research.
[46] D. Pinkel,et al. Somatic activation of KIT in distinct subtypes of melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] D. Pinkel,et al. MC1R germline variants confer risk for BRAF-mutant melanoma. , 2006, Science.
[48] Stephen B Gruber,et al. BRAF and NRAS mutations in melanoma and melanocytic nevi , 2006, Melanoma research.
[49] G. Saldanha,et al. Cutaneous Melanoma Subtypes Show Different BRAF and NRAS Mutation Frequencies , 2006, Clinical Cancer Research.
[50] Howard Y. Chang,et al. Anatomic Demarcation by Positional Variation in Fibroblast Gene Expression Programs , 2006, PLoS genetics.
[51] D. Krahl,et al. The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites. , 2006, International journal of oncology.
[52] D. Whiteman,et al. Anatomic site, sun exposure, and risk of cutaneous melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] L. Chin,et al. Amplification of CDK4 and MDM2 in malignant melanoma , 2006, Genes, chromosomes & cancer.
[54] V. Alexeev,et al. Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes. , 2006, The Journal of investigative dermatology.
[55] J. Fridlyand,et al. Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.
[56] R. MacKie,et al. Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes. , 2005, The Journal of investigative dermatology.
[57] R. Gallagher,et al. Etiologic and Other Factors Predicting Nevus-Associated Cutaneous Malignant Melanoma , 2005, Cancer Epidemiology Biomarkers & Prevention.
[58] T. Kunisada,et al. Cooperative and indispensable roles of endothelin 3 and KIT signalings in melanocyte development , 2005, Developmental dynamics : an official publication of the American Association of Anatomists.
[59] J. Davison,et al. Absence of V599E BRAF mutations in desmoplastic melanomas , 2005, Cancer.
[60] K. Richards,et al. Neural crest cell lineage segregation in the mouse neural tube , 2004, Development.
[61] S. Creuzet,et al. Neural crest cell plasticity and its limits , 2004, Development.
[62] Helmut Fuchs,et al. Effects of G-protein mutations on skin color , 2004, Nature Genetics.
[63] Kazuhiro Takahashi,et al. BRAF point mutations in primary melanoma show different prevalences by subtype. , 2004, The Journal of investigative dermatology.
[64] Ajay N. Jain,et al. Determinants of BRAF mutations in primary melanomas. , 2003, Journal of the National Cancer Institute.
[65] Daniel Pinkel,et al. Classifying melanocytic tumors based on DNA copy number changes. , 2003, The American journal of pathology.
[66] N. Hayward,et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. , 2003, Journal of the National Cancer Institute.
[67] E. Dupin,et al. Development of melanocyte precursors from the vertebrate neural crest , 2003, Oncogene.
[68] P. Meltzer,et al. Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia , 2003, Nature Genetics.
[69] W. Goggins,et al. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate. , 2003, Archives of dermatology.
[70] D. Ruiter,et al. Distinct chromosomal aberrations in sinonasal mucosal melanoma as detected by comparative genomic hybridization , 2003, Genes, chromosomes & cancer.
[71] K. R. Fitch,et al. Genetics of dark skin in mice. , 2003, Genes & development.
[72] L. Kanter,et al. Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[73] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[74] D. Pinkel,et al. Cyclin D1 is a candidate oncogene in cutaneous melanoma. , 2002, Cancer research.
[75] S. Nishikawa,et al. Dominant role of the niche in melanocyte stem-cell fate determination , 2002, Nature.
[76] R. Westendorp,et al. The melanocortin-1-receptor gene is the major freckle gene. , 2001, Human molecular genetics.
[77] J. J. van den Oord,et al. A novel N-ras mutation in malignant melanoma is associated with excellent prognosis. , 2001, Cancer research.
[78] R. MacKie,et al. Development of melanocytic nevi in the first three years of life. , 2000, Journal of the National Cancer Institute.
[79] M. Pasdar,et al. Plasticity of cadherin-catenin expression in the melanocyte lineage. , 2000, Pigment cell research.
[80] M. Catala,et al. The developmental potentials of the caudalmost part of the neural crest are restricted to melanocytes and glia , 2000, Mechanisms of Development.
[81] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[82] T. Godfrey,et al. Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. , 2000, Cancer research.
[83] J. Bulliard. Site‐specific risk of cutaneous malignant melanoma and pattern of Sun exposure in New Zealand , 2000, International journal of cancer.
[84] S. Nishikawa,et al. Regulation of E- and P-cadherin expression correlated with melanocyte migration and diversification. , 1999, Developmental biology.
[85] D. Whiteman,et al. Determinants of melanocyte density in adult human skin , 1999, Archives of Dermatological Research.
[86] J F Aitken,et al. A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. , 1999, American journal of human genetics.
[87] A Biggeri,et al. Cutaneous melanoma histologically associated with a nevus and melanoma de novo have a different profile of risk: results from a case-control study. , 1999, Journal of the American Academy of Dermatology.
[88] R. Gallagher,et al. Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure , 1998, International journal of cancer.
[89] V. Bataille,et al. Solar keratoses: A risk factor for melanoma but negative association with melanocytic naevi , 1998, International journal of cancer.
[90] D. Whiteman,et al. p53 expression and risk factors for cutaneous melanoma: A case‐control study , 1998, International journal of cancer.
[91] S. Nishikawa,et al. Transgene expression of steel factor in the basal layer of epidermis promotes survival, proliferation, differentiation and migration of melanocyte precursors. , 1998, Development.
[92] BL Diffey,et al. The confounding influence of sun exposure in melanoma , 1998, The Lancet.
[93] J. Bulliard,et al. Comparison of the site distribution of melanoma in New Zealand and Canada , 1997, International journal of cancer.
[94] W. Pavan,et al. Melanocyte development in vivo and in neural crest cell cultures: crucial dependence on the Mitf basic-helix-loop-helix-zipper transcription factor. , 1997, Development.
[95] T. Holford,et al. Malignant melanoma risk factors by anatomic site: A case‐control study and polychotomous logistic regression analysis , 1996, International journal of cancer.
[96] N. Hayward,et al. Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. , 1996, The American journal of pathology.
[97] C. la Vecchia,et al. Site distribution of different types of skin cancer: New aetiological clues , 1996, International journal of cancer.
[98] D. English,et al. Benign melanocytic lesions: risk markers or precursors of cutaneous melanoma? , 1995, Journal of the American Academy of Dermatology.
[99] D. Easton,et al. Risk of cutaneous melanoma associated with pigmentation characteristics and freckling: Systematic overview of 10 case‐control studies , 1995 .
[100] Renato Panizzon,et al. Overall and site‐specific risk of malignant melanoma associated with nevus counts at different body sites: A multicenter case‐control study of the german central malignant‐melanoma registry , 1995, International journal of cancer.
[101] H. Höfler,et al. Ras gene mutations: a rare event in nonmetastatic primary malignant melanoma. , 1995, The Journal of investigative dermatology.
[102] J. Bulliard,et al. Latitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand , 1994, Cancer Causes & Control.
[103] V. Siskind,et al. Naevi in schoolchildren in Scotland and Australia , 1994, The British journal of dermatology.
[104] J. Hoeffler,et al. Ras mutations in human melanoma: a marker of malignant progression. , 1994, The Journal of investigative dermatology.
[105] D. English,et al. Melanocytic nevi in children. I. Anatomic sites and demographic and host factors. , 1994, American journal of epidemiology.
[106] N. Martin,et al. Site distribution of cutaneous melanoma in queensland , 1993, International journal of cancer.
[107] A. Green,et al. A theory of site distribution of melanomas: Queensland, Australia , 1992, Cancer Causes & Control.
[108] C. Garbe,et al. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. , 1992, Journal of the American Academy of Dermatology.
[109] J. Nordlund,et al. Neural-tube-derived melanocyte subsets undergo commitment to their distinct lineages in culture. , 1990, Cell differentiation and development : the official journal of the International Society of Developmental Biologists.
[110] J. Liff,et al. Plantar melanoma: Is the incidence of melanoma of the sole of the foot really higher in blacks than whites? , 1990, International journal of cancer.
[111] L. J. Veer,et al. N-ras mutations in human cutaneous melanoma from sun-exposed body sites , 1989, Molecular and cellular biology.
[112] W. Willett,et al. Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women. , 1989, Journal of the National Cancer Institute.
[113] E. Holly,et al. Number of melanocytic nevi as a major risk factor for malignant melanoma. , 1987, Journal of the American Academy of Dermatology.
[114] A. Ackerman,et al. A unifying concept of malignant melanoma: biologic aspects. , 1986, Human pathology.
[115] D. Vågerö,et al. Melanoma and other tumors of the skin among office, other indoor and outdoor workers in Sweden 1961-1979. , 1986, British Journal of Cancer.
[116] V. Siskind,et al. Common acquired naevi and the risk of malignant melanoma , 1985, International journal of cancer.
[117] B. Armstrong,et al. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. , 1984, Journal of the National Cancer Institute.
[118] L. Old,et al. Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? , 1984, Nature.
[119] B K Armstrong,et al. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. , 1984, Journal of the National Cancer Institute.
[120] A. Ackerman. Malignant melanoma: a unifying concept. , 1980, Human pathology.
[121] D. Strickland,et al. Malignant melanoma: social status and outdoor work. , 1980, British Journal of Cancer.
[122] A. Swerdlow. Incidence of malignant melanoma of the skin in England and Wales and its relationship to sunshine. , 1979, British medical journal.
[123] I. Crombie. Variation of melanoma incidence with latitude in North America and Europe. , 1979, British Journal of Cancer.
[124] M. Hinds,et al. Anatomic distribution of malignant melanoma of the skin among non-Caucasians in Hawaii. , 1979, British Journal of Cancer.
[125] I. Crombie. Racial differences in melanoma incidence. , 1979, British Journal of Cancer.
[126] B. Gilchrest,et al. Effects of aging and chronic sun exposure on melanocytes in human skin. , 1979, The Journal of investigative dermatology.
[127] T. Hakulinen,et al. Sunlight as a risk factor of malignant melanoma of the skin , 1978, Cancer.
[128] I. Fleming,et al. Skin cancer in black patients , 1975, Cancer.
[129] W. Clark,et al. The classification of malignant melanoma and its histologic reporting , 1973, Cancer.
[130] K. Magnus. Incidence of malignant melanoma of the skin in Norway, 1955–1970. Variations in time and space and solar radiation , 1973, Cancer.
[131] Morag Bell,et al. A STUDY ON THE EFFECTS OF IBUPROFEN ON THE METABOLISM OF ANTIPYRINE IN MAN , 1973, The Medical journal of Australia.
[132] J. A. Lee,et al. SUNLIGHT AND THE AETIOLOGY OF MALIGNANT MELANOMA: A SYNTHESIS , 1970, The Medical journal of Australia.
[133] W. C. Quevedo,et al. Influence of age and UV on the populations of dopa-positive melanocytes in human skin. , 1969, The Journal of investigative dermatology.
[134] M. G. Lewis,et al. Malignant melanoma in Uganda. , 1968, East African medical journal.
[135] G. Szabó. The regional anatomy of the human integument with special reference to the distribution of hair follicles, sweat glands and melanocytes , 1967, Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences.
[136] M. G. Lewis. Malignant melanoma in Uganda. (The relationship between pigmentation and malignant melanoma on the soles of the feet). , 1967, British Journal of Cancer.
[137] Forbes Ja. Infectious diseases, today and tomorrow. , 1966 .
[138] W. C. Quevedo,et al. Melanocyte populations in UV-irradiated human skin. , 1965, The Journal of investigative dermatology.
[139] R. Winkelmann,et al. PIGMENT ACTIVITY IN DERMAL NEVI INDUCED BY ULTRAVIOLET LIGHT: AN ENZYME HISTOCHEMICAL STUDY. , 1965, The Journal of investigative dermatology.
[140] R. Mitchell. THE EFFECT OF PROLONGED SOLAR RADIATION ON MELANOCYTES OF THE HUMAN EPIDERMIS. , 1963, The Journal of investigative dermatology.
[141] R. Billingham. Announcement:Third Annual Herman Beerman Lecture: Transplantation: Past, Present and Future , 1963 .
[142] Lancaster Ho,et al. Some geographical aspects of the mortality from melanoma in Europeans. , 1956 .
[143] G. Szabó,et al. The Number of Melanocytes in Human Epidermis , 1954, British medical journal.
[144] V. McGovern. MELANOBLASTOMA , 1952, The Medical journal of Australia.
[145] M E RAWLES,et al. Origin of Pigment Cells from the Neural Crest in the Mouse Embryo , 1947, Physiological Zoology.
[146] N. Bhatia. Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis , 2012 .
[147] M. Berwick,et al. Epidemiologic support for melanoma heterogeneity using the surveillance, epidemiology, and end results program. , 2008, The Journal of investigative dermatology.
[148] A. Glick,et al. Endothelin 3 induces skin pigmentation in a keratin-driven inducible mouse model. , 2008, The Journal of investigative dermatology.
[149] C. Warneke,et al. Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma. , 2006, The Journal of investigative dermatology.
[150] P. Leboit,et al. Pathology and genetics of skin tumours , 2006 .
[151] J. Barrett,et al. The effect of sun exposure in determining nevus density in UK adolescent twins. , 2005, The Journal of investigative dermatology.
[152] S. Fraitag. [Melanocytic nevi in children]. , 2004, Annales de pathologie.
[153] P. Meltzer,et al. High frequency of BRAF mutations in nevi , 2003, Nature Genetics.
[154] J. Downward. Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.
[155] D. Duffy,et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? , 2000, American journal of human genetics.
[156] S. Harrison,et al. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. , 1994, Journal of the American Academy of Dermatology.
[157] C. Cordon-Cardo,et al. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. , 1989, Oncogene.
[158] H. Pinkus,et al. Quantitative and qualitative data on the pigment cells of adult human epidermis. , 1957, The Journal of investigative dermatology.
[159] H. Pinkus,et al. Quantitative and Qualitative Data on the Pigment Cells of Adult Human Epidermis1 , 1957 .
[160] H. O. Lancaster. Some geographical aspects of the mortality from melanoma in Europeans. , 1956, The Medical journal of Australia.